Introduction
Brain ischemia is still a serious clinical problem that may lead to permanent neurological deficits and serious complications. Contusion, the initial mechanical damage, may cause edema and pressure causes brain cell death and produces permanent damage. If pressure is removed or continues after the primary injury, the capillary permeability of the damaged area and surroundings increases; with the effect of reactive oxygen species (ROS) and inflammation, more dramatic results may occur due to secondary damage (1) . To prevent ischemia and later damage, current studies have been and continue to be conducted on many chemopreventive agents.
Polyphenols, naturally found in many plants, have antiinflammatory and immunomodulatory effects and are known to show antioxidant effects, cleaning out ROS formed by cellular damage and oxidative stress. Simonyi et al. (2) showed the neuroprotective effect of polyphenols on cerebral ischemic lesions. Studies on a polyphenolic derivative of benzoic acid (2, 3) , syringic acid (SA), have shown it to have chemoprotective (4) and antimicrobial (5) activity. In addition, Morton et al. (6) showed that SA was a strong inhibitor of low-density lipoprotein oxidation, supporting the scavenging of free radicals, reducing production of malondialdehyde, and thus slowing atherosclerosis.
There are no studies on the effects of SA on brain ischemia found in the literature. The aim of this study was to investigate the preventive effect of the active ingredient in SA, a member of the polyphenol group with known antioxidant properties, on injury due to brain ischemia. SA may provide a novel and promising therapeutic strategy for treatment of human cerebral ischemia via antioxidants and antiapoptotic effects.
Materials and methods

Experimental animals and study groups
This study used 32 male Sprague Dawley rats weighing 270-320 g. All animals were fed ad libitum with 7-8 mm pellet rat food (Bil-Yem Ltd., Turkey) and tap water. To provide a 12 h darkness, 12 h light environment, photoperiodic white fluorescent light was used and the temperature and humidity were held at 21 ± 2 °C and 55%-60%, respectively. The methods used for animal experiments were in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals protocols. Permission was granted by the Çanakkale Onsekiz Mart University Animal Experiments Local Ethics Committee (No: 2012/08-16). The rats were randomly divided into 4 groups of 8. Group 1 was the control group (n = 8, no medication or surgical procedure), Group 2 was the sham group (n = 8, intraperitoneal single dose of 1 mL of 10% ethanol and middle cerebral artery occlusion (MCAO), sacrificed at 24 h), Group 3 was the MCAO + SA group sacrificed at 6 h (n = 8, 10 mg/kg SA intraperitoneally), and Group 4 was MCAO + SA group sacrificed at 24 h (n = 8, 10 mg/kg SA intraperitoneally). Before the rats were sacrificed, a craniotomy was performed and the complete brain was obtained, and then they were sacrificed. At the end of the experiment all animals were deeply anesthetized with ketamine (50-60 mg/kg) and decapitated. Brain tissue was investigated histopathologically and immunohistochemically.
Surgical procedure
All groups were anesthetized with 5 mg/kg xylazine (Bayer, Turkey) and 50 mg/kg ketamine hydrochloride (Parke Davis, Turkey) with spontaneous respiration and at room temperature. The rats were incised under sterile conditions on the operating table in the supine position with a right paramedian skin and subdermis incision in the neck. Using the previously described intraluminal filament technique, MCAO with focal cerebral ischemia was induced (7) . To induce MCAO, a 4/0 nylon monofilament suture material (Ethilon Inc., USA) was advanced intraluminally through a small incision in the internal carotid artery until 18 mm distal to the right carotid bifurcation. Five minutes after MCAO was induced, the rats were given 10 mg/kg SA intraperitoneally (Groups 3 and 4; SA was obtained from Sigma-Aldrich's Turkish distributor, İnterlab). Neurological examinations at hours 6 and 24 were completed using a scoring system described by Bederson and modified by Kawamura (8) . At the end of hour 6 Group 3 and at the end of hour 24 Groups 1, 2, and 4 were given a high dose of anesthetic material (ketamine, 50 mg/kg) and sacrificed. Immediately before sacrifice, the brains of the rats were obtained by craniotomy. The tissue was stored in 4% paraformaldehyde solution as previously described (9) . The right hemisphere with MCAO was sent to the laboratory for histopathological examination and tissue biochemical investigation (malondialdehyde (MDA), superoxide dismutase (SOD), and nuclear respiratory factor 1 (NRF1)). 2.3. Tissue MDA levels MDA levels were analyzed for lipid peroxidation products and results were expressed as MDA nmol/g tissue (10) . MDA levels were obtained using the ELISA method.
Tissue SOD activity
Tissue SOD activity was measured with a modified spectrophotometric method at 560 nm as described by Sun et al. (11) . SOD activity was reported as U/mg protein.
NRF1 assays
NRF1 activates the expression of some key genes regulating cell growth and nuclear genes necessary for both mitochondrial DNA transcription and replication as well as heme biosynthesis and respiration. NRF1 controls the apoptosis, proliferation, migration, cellular distribution, and adhesion of target genes. NRF1 levels were measured with the ELISA method (12, 13) . Results are reported as ng mL -1 mg protein -1 .
Histopathological investigation
The brains were labeled and left in 10% neutral formaldehyde solution. After 24 h in fixative, they were washed for 6-8 h in running water and rinsed with an ethanol-xylene series for automatic tissue tracking (Citadel 2000, Thermo Fisher Scientific Shandon, UK), and they were submerged in liquid paraffin. Sections 4-6 µm in thickness were cut for routine hematoxylin and eosin and Luxol fast blue staining, and sections 3-4 µm in thickness were cut for immunohistochemical staining. At appropriate places under light microscope at different magnifications, they were examined and photographed. Sections made for immunohistochemical staining were left in xylene for 20 min after rinsing with alcohol (70%-99%), and were then left in 3% H 2 O 2 solution for 10 min. After washing with PBS they were heated 4 times at 700-800 W for 5-10 min in citrate buffer solution and left in secondary blocking material for 20 min. Different primary antibody dilutions (1/200-1/250) of every preparation (anticaspase-3 antibody (ab4051) and anticaspase-9 antibody [E23] (ab32539), Abcam plc, UK) were left for 60-75 min. Chromogeneous diaminobenzidine solution was used for contrast staining and Mayer's hematoxylin stain was also used. PBS was used for negative controls. The preparations were covered with an appropriate capping material and photographed. Results of immunohistochemical staining tissues were evaluated as % area of immunopositive reaction in 4 different categories: mild (+), moderate (++), severe (+++), and very severe (++++). Preparations with hematoxylin stain were examined in 15 different areas. Each area was 1200 µm, with remaining neuronal cells in the area counted to determine cell density. SPSS 19 .0 (SPSS Inc., USA) was used for statistical analysis. Statistical analysis data are expressed as mean ± SD. The comparisons among pre-and postoperation or drugs were made by using paired t-tests; comparisons between 2 groups were made with unpaired t-tests. The comparisons among the 4 groups were made using oneway analysis of variance followed by Bonferroni posttests. Histopathological findings were evaluated with the Kruskal-Wallis test as they were nonparametric. Statistical significance was accepted as P < 0.05.
Statistical evaluation
Results
The means and standard deviations of SOD, MDA, and NRF1 values in the groups are given in Table 1 .
Comparing the control group to the other groups, the SOD values were reduced, and this was found to be statistically significant (P < 0.05). There was a statistically significant difference between the ischemia group and all other groups (P < 0.05), with no significant difference observed between the 6 and 24 h groups (P > 0.05).
Comparing MDA values between the control group and other groups, the MDA values increased, and this was observed to be statistically significant (P < 0.05). In the ischemia group there was a significant difference between the other groups (P < 0.05), and only in the 6 and 24 h groups was the difference not significant (P > 0.05).
NRF1 values were reduced in the other groups compared to the control group and this was statistically significant (P < 0.05). There was a significant difference between the ischemia group and all other groups (P < 0.05). Only in the 6 and 24 h groups was this difference not significant (P > 0.05).
In the control group, no cellular structure or tissue injury was observed in brain tissue examined with immunohistochemical and hematoxylin and eosin staining for histopathology; neurons and neuroglia with normal morphology and histological appearance were identified. Only in the sham ischemia group given alcohol were focal ischemia lesions observed in both hemispheres, though more so on the right side (Figure 1 ).
Hematoxylin and eosin staining in the sham ischemia group showed that neuronal death was increased, acidophilic neuronal cytoplasm in cells was reduced in size and had pyknotic shape, and severe vacuolization had developed. Histomorphometric red neurons were observed to appear as karyorrhexis-damaged neurons moving from the cortex regions towards the center (Figure 1) .
In the SA (6 h) group, while a negligible increase in red neuron cell counts was observed compared to the control group, there was a significant reduction compared to the sham ischemia group.
Cells in the sham ischemia group stained with Luxol fast blue showed slightly darker blue color for pyramidal neurons compared to the control group and severe vacuolization and edema formed around both granular and pyramidal neurons (Figure 2 ).
In the SA (24 h) group, red neuron cell counts were higher than in the control group. While the cellular degeneration was most severe in the sham ischemia group, it was reduced in the SA groups; however, it was not fully resolved (Table 2) .
Immunoperoxide staining showed edema and microglial cell clusters around damaged areas in brain tissue in the ischemia groups. Although edema was observed in various regions of the hippocampus, it was more often present surrounding granular cells. In areas near the hippocampus, the observed microglial cells and lymphocyte infiltration were at minimal levels.
Caspase-3 immunoactivity was increased, especially in the cortex and external granular layers. Immunoreactivity was observed to be greater in situations with alcohol and long-term ischemia. In the ischemic region, dense groupings of apoptotic cells were identified ( Figure 3 ; Table 3 ). Staining of brain tissue with immunoperoxidase showed reduction in the caspase-3 positivity toward white matter. Along the zone, different cells were observed to have different rates of immune reactivity. Along the cortex and subcortex, glial cells were identified to have strong caspase-3-positive immunoreactivity. In the hippocampus CA1 region, caspase-3 immunoreactivity was observed to be greater in the cytoplasm of granular cells (Figure 3) .
In the group administered alcohol after cerebral ischemia, neuronal degeneration was determined with severe caspase-9 positivity. In the 6 h ischemia group, the immunopositivity for caspase-9 was slightly greater than in the 24 h group. In the large ventricular zone surrounding cortical neurons, caspase-9 staining showed immunopositivity in the shape of rings (Figure 4 ; Table 3 ).
Neurons in the external granular layer and pyramidal cell layers were observed to have varying rates of immunopositivity. The most sensitive area for ischemia was the CA1 region, with the CA3 and dentate gyrus regions identified to have cell structures and morphology more resistant to apoptosis. In the CA1 and CA2 regions of the hippocampus, cells showed high immunoreactivity Table 2 . Histopathological findings for all groups. Neuronal cells in the area were counted to determine cell density.
Groups
Red to caspase-9, while in the CA3-CA4 region and the dentate gyrus area the cells were observed to have mild immunopositivity.
Discussion
To reduce neuronal damage caused by cerebral ischemia, experimental studies of many possible protective agents have been completed. In our study, a polyphenol that can be obtained naturally from plants, SA, was used. In the induced cerebral ischemia model in rats, SA was shown histopathologically to have a protective effect on the ischemic brain area. In addition, after treatment MDA was decreased and SOD and NRF1 values increased in biochemical tests, showing a reduction in the formation of oxidative stress after ischemia.
In spite of developments in treatment of acute strokes, deaths due to stroke are still the third highest cause of death in many countries. In addition, strokes are first in terms of morbidity and cause large economic losses. As a result, the timely and successful treatment of strokes is very important. If the blood flow in the brain reduces by more than 20%, the ATP in brain tissue is quickly consumed and anoxic depolarization waves form. As a result of this, the amount of calcium within cells increases. Increased calcium may cause activation of catabolic enzymes such as protease, kinase, endonuclease, and phospholipase. The increasing calcium within the cells may also cause edema and functional disruption in mitochondria, destroying the energy source of the cell. Free oxygen radicals formed during the ischemic process, along with nitric oxide and peroxynitrite, trigger apoptotic and necrotic cell death through a variety of pathways (14, 15) .
Excessive free oxygen radicals formed during the ischemic process react with polyunsaturated fat acids and cause lipid peroxidation (16) . MDA is the end product of lipid peroxidation and at the same time is accepted as one of the most sensitive markers of lipid peroxidation (17) (18) (19) . In a study by Karaoğlan et al. (20) , temporary forebrain ischemia caused an 80% increase in tissue MDA levels; they found that this increase reduced by 43% with treatment with tirofiban, a glycoprotein receptor blocker. Cirak et al. (21) showed that after head trauma, the tissue MDA levels in rat brains increased in the first 2 h; as time passed it reduced and the use of melatonin reduced serum MDA levels. In our study of rats with induced cerebral ischemia, MDA values were reduced after SA treatment. There was no significant difference between values 6 and 24 h after ischemia.
SOD, an endogenous mitochondrial antioxidant enzyme, is a free radical scavenger that turns superoxide radicals created by cerebral ischemia into less reactive hydrogen peroxide forms. In increased oxidative stress situations, SOD is neutralized by H 2 O 2 and other radicals and thus levels are reduced. In an experimental model in rats, Islekel et al. (22) showed that SOD activity was clearly reduced after cerebral ischemia. Both Deng et al. (23) and Karaoğlan et al. (20) reported that tissue SOD activity fell after cerebral ischemia, while after treatments such as 3,6-dimethamidodibenzopyriodonium gluconate and tirofiban tissue, SOD activity rose again. Kumar et al. (24) showed that decreasing SOD activity increased markedly after SA treatment in hypertensive rats. The main mechanism of the 50 mg/kg dose of SA treatment was associated with antioxidant effect in this study. In our study, after SA treatment the rise in SOD values indicated a reduction in oxidative stress. This supports the view that SA has antioxidant properties.
Mitochondria are important regulators of the metabolic activity of cells while also enabling production and breakdown of free radicals. Mitochondrial biogenesis is activated in response to cellular stress or environmental stimuli by many different signals. NRF1 and NRF2 are mitochondrial transcription factors that activate the majority of genes coding subunits of the respiratory complex. Kumari et al. (25) induced cerebral ischemia/ reperfusion in normal and hyperglycemic rats and showed that after the reperfusion period NRF1 levels increased. In our study, which simulated an embolism in the human brain, the intraluminal filament was not retracted to allow reperfusion. NRF1 values, a marker for mitochondrial biogenesis, were reduced in the MCAO group. In the ischemic groups with SA treatment, a significant increase was observed. In accordance with our study, in the literature the increase in NRF1 values in the ischemia/ reperfusion groups was in proportion with the reperfusion time and was shown to increase further with the use of neuroprotective agents (12, 13, 25, 26) (Table 1) .
In ischemic stroke, apoptosis may begin by 2 paths: intrinsic or extrinsic. Cytochrome c and caspase-3 stimulation triggered by mitochondria forms the intrinsic pathway (27) . Caspase-3 and caspase-9 are known to be important in apoptosis caused by ischemia of neuronal cells. Studies of apoptotic neuronal cells found that caspase-3 may be activated by both intrinsic and extrinsic signal pathways and as a result supported the idea that caspase-3 plays a key role in ischemic stroke apoptosis (28) . Activated caspase-3 causes breakdown of DNA (29) . Some studies have shown a relationship between DNA breakdown and development of ischemic infarction (30). Li et al. (31) , in a temporary focal cerebral ischemia model in rats, showed that caspase-3 and caspase-9 activity clearly increased compared to the control group, but this was not statistically significant. In our study, in the brain tissue along the cortex and subcortex, glial cells were identified to have positive immunoreactivity for caspase-3, while in the hippocampus CA1 region it was more pronounced in the cytoplasm of granular cells. Neuronal degeneration after cerebral ischemia was determined by severe caspase-9 positivity. Especially in the 6 h group after ischemia, caspase-9 immunopositivity was observed to be slightly greater than in the 24 h group (Figures 3 and 4) . Kim et al. (32) used 2 different doses of caffeic acid-SA treatment at 10 and 20 mg/kg in experimental cerebral ischemia. They observed moderate neuroprotective effects with 10 mg/kg and strong neuroprotective effects with 20 mg/kg in the hippocampus CA1 region. In the present study, it was shown that 10 mg/kg SA treatment had a neuroprotective effect both biochemically and pathologically, despite induced permanent cerebral ischemia.
In conclusion, data from our study support the view that in cerebral ischemia, SA treatment reduces neuronal degeneration as a result of oxidative stress and may be an alternative treatment. More comprehensive studies are definitely required.
